Ibnsina PharmaEGX: ISPH

Ibnsina Pharma Q2 Consol Profit EGP 206.9 Million

· Issued by Ibnsina Pharma

IBNSINA PHARMA EGX:ISPH:

  • Q2 CONSOL NET PROFIT ATTRIBUTABLE EGP 206.9 MILLION

  • Q2 CONSOL NET SALES EGP 18 BILLION